PIVOTAL
2019
Proactive IV Iron Therapy in Haemodialysis Patients
In 2,141 incident haemodialysis patients, proactive high-dose intravenous iron reduced death and cardiovascular events compared with a reactive low-dose regimen.
Result
Efficacy: Composite of death, MI, stroke or HF hospitalisationHR 0.85 (95% CI 0.73-1.00) · P = 0.04
Below 1 favours proactive high-dose intravenous iron, above 1 favours a reactive low-dose regimen.
- Absolute difference
- 3.0 points
The absolute difference is derived from the event rates.
Also reported: Also lowering the ESA dose.
- Subtopic
- Iron therapy
- Design
- Open-label RCT
- Relevance
- Important: one of several pillars.
- Cited in
- KDIGO 2026 Anaemia in CKD
- Source
- Macdougall IC, et al. N Engl J Med. 2019;380(5):447-458.doi 10.1056/NEJMoa1810742
Discussion & critique
Higher iron dosing proved safe and effective without an excess infection signal.